Point of care HPV 16/18/45 DNA test for cervical cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA250663
- Recipient
-
Crosslife Technologies Inc. UEI LFE6DJ6KL4E5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,288,388
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $994,439 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $994,004 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,945 |
Quick answers
Who received award R44CA250663?
R44CA250663 was awarded to Crosslife Technologies Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2020.
How much is award R44CA250663 worth?
$2,288,388 has been obligated on R44CA250663.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award